ACUTE REJECTION OF VASCULAR HEART ALLOGRAFTS BY PERFORIN-DEFICIENT MICE

被引:88
作者
SHULZ, M
SCHUURMAN, HJ
JOERGENSEN, J
STEINER, C
MEERLOO, T
KAGI, D
HENGARTNER, H
SCHREIER, MH
BURKI, K
LEDERMANN, B
机构
[1] SANDOZ PHARMA LTD, PRECLIN RES, CH-4002 BASEL, SWITZERLAND
[2] UNIV ZURICH, DEPT PATHOL, INST EXPTL IMMUNOL, CH-8006 ZURICH, SWITZERLAND
关键词
PERFORIN; GRAFT REJECTION; MICE;
D O I
10.1002/eji.1830250225
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To study the role of perforin in cell-mediated graft rejection, vascularized hearts were grafted to perforin-deficient C57BL/6 and control C57BL/6 recipient mice. Fully allogeneic heart grafts (BALB/c) were acutely rejected by both recipients within 6 days. Peritoneal exudate lymphocytes from control mice but not from perforin-deficient mice exhibit a strong alloreactive cytotoxic activity in vitro. Histological analysis of the rejected tissues demonstrated extensive mononuclear cell infiltrates in both recipients. Flow cytometry analysis and immunohistology of graft-infiltrating cells showed similar proportions of lymphocyte subsets (CD8 much greater than CD4). Collectively, these data indicate that perforin is not essential in the cell-mediated acute rejection of a fully mismatched heart allograft. However, perforin-dependent effector mechanisms appeared to be limiting in the T cell-mediated rejection of heart allografts differing only at a single major histocompatibility complex class I antigen (bm1), because these grafts survived longer (mean 87.8 days) in perforin-deficient than in control mice (mean 31.5 days).
引用
收藏
页码:474 / 480
页数:7
相关论文
共 36 条
[1]   CELL-MEDIATED CYTOTOXICITY - CONTACT AND SECRETED FACTORS [J].
APASOV, S ;
REDEGELD, F ;
SITKOVSKY, M .
CURRENT OPINION IN IMMUNOLOGY, 1993, 5 (03) :404-410
[2]   PROCESSED MHC CLASS-I ALLOANTIGEN AS THE STIMULUS FOR CD4+ T-CELL DEPENDENT ANTIBODY-MEDIATED GRAFT-REJECTION [J].
BRADLEY, JA ;
MOWAT, AM ;
BOLTON, EM .
IMMUNOLOGY TODAY, 1992, 13 (11) :434-438
[3]   LPR AND GLD - SINGLE GENE MODELS OF SYSTEMIC AUTOIMMUNITY AND LYMPHOPROLIFERATIVE DISEASE [J].
COHEN, PL ;
EISENBERG, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 1991, 9 :243-269
[4]   PRIMARILY VASCULARIZED ALLOGRAFTS OF HEARTS IN MICE - ROLE OF H-2D, H-2K, AND NON-H-2 ANTIGENS IN REJECTION [J].
CORRY, RJ ;
WINN, HJ ;
RUSSELL, PS .
TRANSPLANTATION, 1973, 16 (04) :343-350
[5]   CYTOKINES AS MEDIATORS OF ORGAN GRAFT-REJECTION AND TOLERANCE [J].
DALLMAN, MJ .
CURRENT OPINION IN IMMUNOLOGY, 1993, 5 (05) :788-793
[6]   REJECTION OF SKIN ALLOGRAFTS BY INDIRECT ALLORECOGNITION OF DONOR CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDES [J].
FANGMANN, J ;
DALCHAU, R ;
FABRE, JW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (06) :1521-1529
[7]   T-CELL REQUIREMENTS FOR THE REJECTION OF RENAL-ALLOGRAFTS BEARING AN ISOLATED CLASS-I MHC DISPARITY [J].
GRACIE, JA ;
BOLTON, EM ;
PORTEOUS, C ;
BRADLEY, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (06) :1547-1557
[8]   GRANZYME-A AND PERFORIN AS MARKERS FOR REJECTION IN CARDIAC TRANSPLANTATION [J].
GRIFFITHS, GM ;
NAMIKAWA, R ;
MUELLER, C ;
LIU, CC ;
YOUNG, JDE ;
BILLINGHAM, M ;
WEISSMAN, I .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (03) :687-692
[9]  
HALL BM, 1991, TRANSPLANTATION, V77, P167
[10]   MECHANISM OF LYMPHOCYTE-MEDIATED CYTO-TOXICITY [J].
HENKART, PA .
ANNUAL REVIEW OF IMMUNOLOGY, 1985, 3 :31-58